(SAM) Boston Beer - Overview
Exchange: NYSE •
Country: United States •
Currency: USD •
Type: Common Stock •
ISIN: US1005571070
Stock: Beer, Cider, Seltzer, Malt Beverage
Total Rating 52
Risk 85
Buy Signal 0.64
EPS (Earnings per Share)
Revenue
| Risk 5d forecast | |
|---|---|
| Volatility | 32.3% |
| Relative Tail Risk | -8.51% |
| Reward TTM | |
|---|---|
| Sharpe Ratio | 0.10 |
| Alpha | -7.68 |
| Character TTM | |
|---|---|
| Beta | 0.378 |
| Beta Downside | 0.140 |
| Drawdowns 3y | |
|---|---|
| Max DD | 52.49% |
| CAGR/Max DD | -0.23 |
Description: SAM Boston Beer January 13, 2026
The Boston Beer Company (NASDAQ: SAM) is a U.S.-focused alcoholic-beverage producer best known for its Samuel Adams Boston Lager, and it also markets hard ciders, flavored malt drinks, and hard seltzers under brands such as Truly, Angry Orchard, Twisted Tea, Dogfish Head, Angel City and Coney Island. Its products reach consumers through a wholesale network that supplies grocery, convenience, liquor, and on-premise outlets, as well as e-commerce channels, and the company exports to Canada, Mexico and other international markets.
Key recent metrics: 2023 net sales were approximately $2.1 billion, with a 7% year-over-year increase driven largely by a 15% rise in hard-seltzer volume; gross margin slipped to 41% from 43% as commodity costs (barley, corn) rose, highlighting price-sensitivity in the premium-craft segment. The broader brewers’ industry is currently influenced by three macro drivers-consumer shift toward lower-calorie, ready-to-drink formats, tightening supply-chain constraints on raw materials, and the lagging recovery of on-premise traffic post-pandemic.
For a deeper, data-rich look at SAM’s valuation dynamics, you might find ValueRay’s analyst toolkit worth a quick browse.
Piotroski VR‑10 (Strict, 0-10) 8.5
| Net Income: 92.2m TTM > 0 and > 6% of Revenue |
| FCF/TA: 0.17 > 0.02 and ΔFCF/TA 4.58 > 1.0 |
| NWC/Revenue: 10.56% < 20% (prev 13.57%; Δ -3.01% < -1%) |
| CFO/TA 0.22 > 3% & CFO 272.1m > Net Income 92.2m |
| Net Debt (-209.6m) to EBITDA (249.2m): -0.84 < 3 |
| Current Ratio: 1.83 > 1.5 & < 3 |
| Outstanding Shares: last quarter (10.8m) vs 12m ago -7.29% < -2% |
| Gross Margin: 47.72% > 18% (prev 0.44%; Δ 4728 % > 0.5%) |
| Asset Turnover: 150.8% > 50% (prev 145.0%; Δ 5.74% > 0%) |
| Interest Coverage Ratio: 5.66 > 6 (EBITDA TTM 249.2m / Interest Expense TTM 28.0m) |
Altman Z'' 3.18
| A: 0.17 (Total Current Assets 461.8m - Total Current Liabilities 252.6m) / Total Assets 1.25b |
| B: 0.18 (Retained Earnings 220.8m / Total Assets 1.25b) |
| C: 0.12 (EBIT TTM 158.4m / Avg Total Assets 1.31b) |
| D: 0.66 (Book Value of Equity 220.4m / Total Liabilities 335.6m) |
| Altman-Z'' Score: 3.18 = A |
Beneish M -3.35
| DSRI: 0.91 (Receivables 84.3m/94.1m, Revenue 1.98b/2.00b) |
| GMI: 0.92 (GM 47.72% / 43.95%) |
| AQI: 0.97 (AQ_t 0.14 / AQ_t-1 0.14) |
| SGI: 0.99 (Revenue 1.98b / 2.00b) |
| TATA: -0.14 (NI 92.2m - CFO 272.1m) / TA 1.25b) |
| Beneish M-Score: -3.35 (Cap -4..+1) = AA |
What is the price of SAM shares?
As of February 08, 2026, the stock is trading at USD 246.76 with a total of 139,925 shares traded.
Over the past week, the price has changed by +15.51%, over one month by +22.12%, over three months by +23.72% and over the past year by +2.07%.
Over the past week, the price has changed by +15.51%, over one month by +22.12%, over three months by +23.72% and over the past year by +2.07%.
Is SAM a buy, sell or hold?
Boston Beer has received a consensus analysts rating of 3.19.
Therefor, it is recommend to hold SAM.
- StrongBuy: 2
- Buy: 2
- Hold: 10
- Sell: 1
- StrongSell: 1
What are the forecasts/targets for the SAM price?
| Issuer | Target | Up/Down from current |
|---|---|---|
| Wallstreet Target Price | 240.2 | -2.7% |
| Analysts Target Price | 240.2 | -2.7% |
| ValueRay Target Price | 246.9 | 0% |
SAM Fundamental Data Overview February 02, 2026
P/E Trailing = 24.3303
P/E Forward = 18.7266
P/S = 1.1738
P/B = 2.4539
P/EG = 0.6279
Revenue TTM = 1.98b USD
EBIT TTM = 158.4m USD
EBITDA TTM = 249.2m USD
Long Term Debt = 936.0k USD (from longTermDebtTotal, last fiscal year)
Short Term Debt = 12.6m USD (from shortTermDebt, last quarter)
Debt = 40.9m USD (from shortLongTermDebtTotal, last quarter)
Net Debt = -209.6m USD (from netDebt column, last quarter)
Enterprise Value = 2.12b USD (2.33b + Debt 40.9m - CCE 250.5m)
Interest Coverage Ratio = 5.66 (Ebit TTM 158.4m / Interest Expense TTM 28.0m)
EV/FCF = 9.99x (Enterprise Value 2.12b / FCF TTM 211.9m)
FCF Yield = 10.01% (FCF TTM 211.9m / Enterprise Value 2.12b)
FCF Margin = 10.69% (FCF TTM 211.9m / Revenue TTM 1.98b)
Net Margin = 4.66% (Net Income TTM 92.2m / Revenue TTM 1.98b)
Gross Margin = 47.72% ((Revenue TTM 1.98b - Cost of Revenue TTM 1.04b) / Revenue TTM)
Gross Margin QoQ = 50.81% (prev 49.75%)
Tobins Q-Ratio = 1.70 (Enterprise Value 2.12b / Total Assets 1.25b)
Interest Expense / Debt = 4.02% (Interest Expense 1.64m / Debt 40.9m)
Taxrate = 28.05% (18.0m / 64.2m)
NOPAT = 114.0m (EBIT 158.4m * (1 - 28.05%))
Current Ratio = 1.83 (Total Current Assets 461.8m / Total Current Liabilities 252.6m)
Debt / Equity = 0.04 (Debt 40.9m / totalStockholderEquity, last quarter 911.0m)
Debt / EBITDA = -0.84 (Net Debt -209.6m / EBITDA 249.2m)
Debt / FCF = -0.99 (Net Debt -209.6m / FCF TTM 211.9m)
Total Stockholder Equity = 909.1m (last 4 quarters mean from totalStockholderEquity)
RoA = 7.02% (Net Income 92.2m / Total Assets 1.25b)
RoE = 10.15% (Net Income TTM 92.2m / Total Stockholder Equity 909.1m)
RoCE = 17.41% (EBIT 158.4m / Capital Employed (Equity 909.1m + L.T.Debt 936.0k))
RoIC = 12.54% (NOPAT 114.0m / Invested Capital 909.1m)
WACC = 7.23% (E(2.33b)/V(2.37b) * Re(7.31%) + D(40.9m)/V(2.37b) * Rd(4.02%) * (1-Tc(0.28)))
Discount Rate = 7.31% (= CAPM, Blume Beta Adj.) -> floored to rf + 0.7*ERP = 7.95%
Shares Correlation 3-Years: -100.0 | Cagr: -5.65%
[DCF Debug] Terminal Value 83.35% ; FCFF base≈195.8m ; Y1≈232.9m ; Y5≈364.5m
Fair Price DCF = 876.9 (EV 7.32b - Net Debt -209.6m = Equity 7.53b / Shares 8.59m; r=7.23% [WACC]; 5y FCF grow 20.19% → 2.90% )
EPS Correlation: 15.80 | EPS CAGR: 2.38% | SUE: 1.96 | # QB: 4
Revenue Correlation: 22.06 | Revenue CAGR: 12.28% | SUE: -0.39 | # QB: 0
EPS next Quarter (2026-03-31): EPS=2.04 | Chg30d=+0.001 | Revisions Net=+0 | Analysts=7
EPS next Year (2026-12-31): EPS=10.89 | Chg30d=+0.030 | Revisions Net=+0 | Growth EPS=+16.4% | Growth Revenue=+1.0%
P/E Forward = 18.7266
P/S = 1.1738
P/B = 2.4539
P/EG = 0.6279
Revenue TTM = 1.98b USD
EBIT TTM = 158.4m USD
EBITDA TTM = 249.2m USD
Long Term Debt = 936.0k USD (from longTermDebtTotal, last fiscal year)
Short Term Debt = 12.6m USD (from shortTermDebt, last quarter)
Debt = 40.9m USD (from shortLongTermDebtTotal, last quarter)
Net Debt = -209.6m USD (from netDebt column, last quarter)
Enterprise Value = 2.12b USD (2.33b + Debt 40.9m - CCE 250.5m)
Interest Coverage Ratio = 5.66 (Ebit TTM 158.4m / Interest Expense TTM 28.0m)
EV/FCF = 9.99x (Enterprise Value 2.12b / FCF TTM 211.9m)
FCF Yield = 10.01% (FCF TTM 211.9m / Enterprise Value 2.12b)
FCF Margin = 10.69% (FCF TTM 211.9m / Revenue TTM 1.98b)
Net Margin = 4.66% (Net Income TTM 92.2m / Revenue TTM 1.98b)
Gross Margin = 47.72% ((Revenue TTM 1.98b - Cost of Revenue TTM 1.04b) / Revenue TTM)
Gross Margin QoQ = 50.81% (prev 49.75%)
Tobins Q-Ratio = 1.70 (Enterprise Value 2.12b / Total Assets 1.25b)
Interest Expense / Debt = 4.02% (Interest Expense 1.64m / Debt 40.9m)
Taxrate = 28.05% (18.0m / 64.2m)
NOPAT = 114.0m (EBIT 158.4m * (1 - 28.05%))
Current Ratio = 1.83 (Total Current Assets 461.8m / Total Current Liabilities 252.6m)
Debt / Equity = 0.04 (Debt 40.9m / totalStockholderEquity, last quarter 911.0m)
Debt / EBITDA = -0.84 (Net Debt -209.6m / EBITDA 249.2m)
Debt / FCF = -0.99 (Net Debt -209.6m / FCF TTM 211.9m)
Total Stockholder Equity = 909.1m (last 4 quarters mean from totalStockholderEquity)
RoA = 7.02% (Net Income 92.2m / Total Assets 1.25b)
RoE = 10.15% (Net Income TTM 92.2m / Total Stockholder Equity 909.1m)
RoCE = 17.41% (EBIT 158.4m / Capital Employed (Equity 909.1m + L.T.Debt 936.0k))
RoIC = 12.54% (NOPAT 114.0m / Invested Capital 909.1m)
WACC = 7.23% (E(2.33b)/V(2.37b) * Re(7.31%) + D(40.9m)/V(2.37b) * Rd(4.02%) * (1-Tc(0.28)))
Discount Rate = 7.31% (= CAPM, Blume Beta Adj.) -> floored to rf + 0.7*ERP = 7.95%
Shares Correlation 3-Years: -100.0 | Cagr: -5.65%
[DCF Debug] Terminal Value 83.35% ; FCFF base≈195.8m ; Y1≈232.9m ; Y5≈364.5m
Fair Price DCF = 876.9 (EV 7.32b - Net Debt -209.6m = Equity 7.53b / Shares 8.59m; r=7.23% [WACC]; 5y FCF grow 20.19% → 2.90% )
EPS Correlation: 15.80 | EPS CAGR: 2.38% | SUE: 1.96 | # QB: 4
Revenue Correlation: 22.06 | Revenue CAGR: 12.28% | SUE: -0.39 | # QB: 0
EPS next Quarter (2026-03-31): EPS=2.04 | Chg30d=+0.001 | Revisions Net=+0 | Analysts=7
EPS next Year (2026-12-31): EPS=10.89 | Chg30d=+0.030 | Revisions Net=+0 | Growth EPS=+16.4% | Growth Revenue=+1.0%